BioMarin Pharmaceutical, Inc. (BMRN)

60.16 -0.98 (-1.60%) USD  |  NASDAQ  |  Dec 24, 12:59
60.17 +0.01 (+0.02%) After-Hours: 13:52
More

BioMarin Pharmaceutical SG&A Expense (TTM): 973.41M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. 353.07M
Gilead Sciences, Inc. 5.886B
Merck & Co., Inc. 10.70B
AbbVie, Inc. 13.97B
Bristol Myers Squibb Co. 7.222B